Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection
Macula Z ORO 60 comprimés - Complément pour la vision - DMLA
Topical glaucoma medications – Clinical implications for the ocular surface - ScienceDirect
Bioavailability and spatial distribution of fatty acids in the rat retina after dietary omega-3 supplementation
Metabolites | Free Full-Text | Proteomic Analysis of Tears and Conjunctival Cells Collected with Schirmer Strips Using timsTOF Pro: Preanalytical Considerations | HTML
MARKS PUBLISHED FOR OPPOSITION
Macula-Z visée oculaire
Incidence of Rhegmatogenous Retinal Detachment Following Macular Surgery in France Between 2006 and 2016 - American Journal of Ophthalmology
European Ophthalmic Review
Defining Dry Eye from a Clinical Perspective
In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human He
IJMS | Free Full-Text | Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease | HTML
Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas. - Abstract - Europe PMC
Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas | Journal of Ocular Pharmacology and Therapeutics
Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer - Nanoscale (RSC Publishing) DOI:10.1039/D1NR03034E
Pharmaceuticals | Free Full-Text | A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome ...
In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells | PLOS ONE
In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells | PLOS ONE
